Age-associated differences in immunoglobulin G1 (IgG1) and IgG2 subclass antibodies to pneumococcal polysaccharides following vaccination

Infection and Immunity

Volumn 67, Issue 9, 1999, Pages 4935-4938

  Lottenbach, Kathleen R ^a,e   Mink, Chrisanna M ^b   Barenkamp, Stephen J ^a   Anderson, Edwin L ^a   Homan, Sharon M ^c   Powers, Douglas C ^d  

^a SAINT LOUIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b CEDARS SINAI MEDICAL CENTER   (United States)

^c SAINT LOUIS UNIVERSITY   (United States)

^d EASTERN VIRGINIA MEDICAL SCHOOL   (United States)

^e S LOUIS UNIV HLTH SCIENCES CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN G1; IMMUNOGLOBULIN G2; PNEUMOCOCCUS VACCINE;

ACTIVE IMMUNIZATION; ADULT; AGE; ANTIBODY RESPONSE; ANTIBODY TITER; ARTICLE; HUMAN; IMMUNOGLOBULIN PRODUCTION; MAJOR CLINICAL STUDY; PRESCHOOL CHILD; PRIORITY JOURNAL; STREPTOCOCCUS INFECTION;

EID: 0032774775     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/iai.67.9.4935-4938.1999     Document Type: Article

References (19)

1. Anttila, M., J. Eskola, H. Åhman, and H. Käyhty. 1999. Differences in the avidity of antibodies evoked by four different pneumococcal conjugate vaccines in early childhood. Vaccine 17:1970-1977.
2. Bardardottir, E., S. Jonsson, I. Jonsdottir, A. Sigfusson, and H. Valdimarson. 1990. IgG subclass response and opsonization of Streptococcus pneumoniae after vaccination of healthy adults. J. Infect. Dis. 162:482-488.
3. Barrett, D. J., and E. M. Ayoub. 1986. IgG2 subclass restriction of antibodies to pneumococcal polysaccharides. Clin. Exp. Immunol. 63:127-134.
4. Freijd, A., L. Hammarstrom, M. A. A. Persson, and C. I. E. Smith. 1984. Plasma anti-pneumococcal antibody activity of the IgG class and subclasses in otitis prone children. Clin. Exp. Immunol. 56:233-238.
5. French, M., and G. Harrison. 1984. Serum IgG subclass concentration in healthy adults: a study using monoclonal antisera. Clin. Exp. Immunol. 56:473-475.
6. Hamilton, R. G. 1991. Application of engineered chimeric antibodies to the calibration of human antibody standards. Ann. Biol. Clin. 49:242-248.
7. Hermann, D. J., R. G. Hamilton, T. Barington, C. E. Frasch, G. Arakere, O. Makela, L. A. Mitchell, J. Nagel, G. T. Rijkers, B. Zegers, et al. 1992. Quantitation of human IgG subclass antibodies to Haemophilus influenzae type b capsular polysaccharide: results of an international collaborative study using enzyme immunoassay methodology. J. Immunol. Methods 148:101-114.
8. Hussain, R., R. W. Poindexter, R. Wistar, and C. B. Reimer. 1986. Use of monoclonal antibodies to quantify subclasses of human IgG. J. Immunol. Methods 93:89-96.
9. Jefferis, R., C. B. Reimer, F. Skvaril, G. G. de Lange, D. M. Goodall, T. L. Bentley, D. J. Phillips, A. Vlug, S. Harada, J. Radl, et al. 1992. Evaluation of monoclonal antibodies having specificity for human IgG subclass: results of an IUIS/WHO collaborative study. Immunol. Lett. 31:143-168.
10. Nahm, M. H., J. V. Olander, and M. Magyarlaki. 1997. Identification of cross-reactive antibodies with low opsonophagocytic activity for Streptococcus pneumoniae. J. Infect. Dis. 176:698-703.
11. Nahm, M. H., J. Ward, S. Chang, and X. H. Yu. 1997. Young children may produce antibodies against Streptococcus pneumoniae that are reactive but not opsonophagocytic to cross-reactive serotypes, abstr. G-82, p. 207. In Abstracts of the 37th Interscience Conference on Antimicrobial Agents and Chemotherapy. American Society for Microbiology, Washington, D.C.
12. Park, M. K., Y. Sun, J. V. Olander, J. W. Hoffmann, and M. H. Nahm. 1996. The repertoire of human antibodies to the carbohydrate capsule of Streptococcus pneumoniae 6B. J. Infect. Dis. 174:75-82.
13. Powers, D. C., E. L. Anderson, K. R. Lottenbach, and C. M. Mink. 1996. Reactogenicity and immunogenicity of a protein-conjugated pneumococcal oligosaccharide vaccine in older adults. J. Infect. Dis. 173:1014-1018.
14. Powers, D. C., K. R. Lottenbach, S. J. Barenkamp, E. L. Anderson, and C. M. Mink. 1997. Age associated differences in IgG1 and IgG2 subclass antibodies to pneumococcal (Pn) polysaccharides (Ps) following vaccination, abstr. G-87, p. 208. In Abstracts of the 37th Interscience Conference on Antimicrobial Agents and Chemotherapy. American Society for Microbiology, Washington, D.C.
15. Quataert, S. A., C. S. Kirch, L. J. Quackenbush Wiedle, D. C. Phipps, S. Strohmeyer, C. O. Cimino, J. Skuse, and D. V. Madore. 1995. Assignment of weight-based antibody units to a human antipneumococcal standard reference serum, lot 89-S. Clin. Diag. Lab. Immunol. 2:590-597.
16. Reizenstein, E., H. O. Hallander, W. C. Blackwelder, I. Kuhn, M. Ljungman, and R. Mollby. 1995. Comparison of five calculation methods for antibody ELISA procedures using pertussis serology as a model. J. Immunol. Methods 183:279-290.
17. Robbins, J. B., and R. Schneerson. 1990. Polysaccharide protein conjugates: a new generation of vaccines. J. Infect. Dis. 161:821-832.
18. Sarvas, H., N. Rautonen, S. Sipinen, and O. Makela. 1989. IgG subclasses of pneumococcal antibodies - effect of allotype G2m(n). Scand. J. Immunol. 29:229-237.
19. Soininen, A., I. Seppälä, T. Nieminen, J. Eskola, and H. Käyhty. 1999. IgG subclass distribution of antibodies after vaccination of adults with pneumococcal conjugate vaccines. Vaccine 17:1889-1897.